In renal cell carcinoma it has been shown that the loss of VHL and hypoxia can upregulate PAX2 expression [26].Therefore, determining factors and their signalling pathways which are involved in the progression of melanoma which can upregulate PAX2 expression, may identify new therapeutic target proteins for the treatment of melanoma patients. Here, PAX2 is linked to hereditary clear cell renal cell carcinoma.